EUVIMEDEUVIMED entdecken
Crossref

Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System

Niti Sureka, Charanjeet Ahluwalia, Sana Ahuja, Neha Kawatra Madan, Meetu Agrawal, Sunil Ranga

Acta Cytologica · 2025

DOI: 10.1159/000544807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cytologica, 2025. Verfasst von Niti Sureka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms, Thyroid Gland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Thyroid nodules are common, with about 5% being malignant, necessitating accurate evaluation to avoid unnecessary surgeries. Fine-needle aspiration cytology (FNAC) is a crucial diagnostic tool, and the 2023 Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) refines FNAC’s diagnostic accuracy and risk stratification for thyroid lesions. Materials and Methods: This retrospective study reclassified thyroid FNAs performed at a tertiary care centre from January 2023 to June 2024 using the 2023 TBSRTC and compared with available histopathological diagnoses. FNAC slides were reviewed and reclassified according to the 2023 TBSRTC categories by two cytopathologists. Statistical analysis included sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy.

Results

The study included 387 patients (female-to-male ratio of 4:1), with 8% non-diagnostic, 61.5% benign, 9% AUS, 7.5% FN, 8% SFM, and 6% malignant cases. Histopathological correlation was available for 190 cases, revealing 126 benign and 64 malignant lesions. Considering NIFTP as benign on histopathology, the ROM for benign, FN, and SFM categories was 10%, 38%, and 69.2%, respectively. The highest sensitivity (88.2%) was achieved when AUS, FN, SFM, and malignant categories were considered positive for malignancy. The highest diagnostic accuracy (85.4%) was observed when SFM and malignant categories were considered positive.

Conclusion

FNAC, guided by the 2023 TBSRTC, is a reliable diagnostic tool for thyroid lesions, offering high sensitivity and specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleThyroid NeoplasmsThyroid GlandHumansBiopsy, Fine-NeedleFemaleMaleRetrospective StudiesMiddle AgedAdultAgedPredictive Value of TestsYoung AdultSensitivity and SpecificityReproducibility of ResultsAged, 80 and overAdolescent

Stichwörter der Autor:innen

Atypia of undetermined significanceFine-needle aspiration cytologyNon-invasive follicular thyroid neoplasm with papillary-like nuclear featuresThyroid

Autor:innen und Institutionen

  • Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

Zitieren

APA

Sureka, N., Ahluwalia, C., Ahuja, S., Madan, N. K., Agrawal, M., & Ranga, S. (2025). Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System. Acta Cytologica. https://doi.org/10.1159/000544807

Vancouver

Sureka N, Ahluwalia C, Ahuja S, Madan NK, Agrawal M, Ranga S. Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System. Acta Cytologica. 2025. doi:10.1159/000544807

BibTeX
@article{Sureka2025,
  author = {Sureka, Niti and Ahluwalia, Charanjeet and Ahuja, Sana and Madan, Neha Kawatra and Agrawal, Meetu and Ranga, Sunil},
  title = {Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System},
  journal = {Acta Cytologica},
  year = {2025},
  doi = {10.1159/000544807}
}
Kostenlos starten →